Merz—Committed to helping you treat movement disorders and spasticity

Driving innovation to help achieve a better patient experience

As a global leader in neurology, Merz is driven to deliver meaningful treatment options and a better patient experience in order to meet the unique needs of each person we serve. XEOMIN® (incobotulinumtoxinA) and our proprietary manufacturing process exemplify this commitment.

A 100-year history of stability, integrity, and family ownership


XEOMIN is well established in clinical practice both in the United States and around the world. It has been used worldwide in 49 countries.1

To find out about other Merz products, visit us at Merz North America.

Reference

  1. Data on file. Raleigh, NC: Merz North America, Inc.